Ticker Symbol: NGM
Ngm Biopharmaceuticals Inc
$19.96 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001426332
Company Profile
NGM is a biopharmaceutical company focused on discovering and developing novel therapeutics based on scientific understanding of key biological pathways underlying liver and metabolic diseases, retinal diseases and cancer. The Company leverages its biology-centric drug discovery approach to uncover novel mechanisms of action and generate proprietary insights that enable it to move rapidly into proof-of-concept studies and deliver potential first-in-class medicines to patients. NGM aspires to operate one of the most productive research and development engines in the biopharmaceutical industry.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 333 Oyster Point Blvd
Website: www.ngmbio.com
CEO: David Woodhouse
Tags:
- Biotechnology
- Health Technology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $1.20
Change:
$0.04
(
3.45%)
Days Range: $1.10 - $1.22
Beta: 1.56
52wk. High: $6.14
52wk. Low: $0.97
Ytd. Change -73.44%
50 Day Moving Average: $1.27
200 Day Moving Average: $2.64
Shares Outstanding: 82715507
Valuation
Market Cap: 9.9B
PE Ratio: -
EPS (TTM): -2.07
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A